The Surgical Management of Vertebral Compression Fractures: Indications, techniques, and outcomes

This course has expired. You may still view the lesson, however, no credit will be issued.

Agenda

Treatment options for osteoporotic compression fractures
Reginald Knight, MD

Outcomes
Mark Dekutoski, MD

Case presentation
Reginald Knight, MD

Discussion of case
Moderator: Reginald Knight, MD
Panel: Daniel Resnick, MD, Mark Dekutoski, MD

Media

Internet

Release Date: August 20, 2010
Expiration Date: August 19, 2011

Faculty

  • Mark B. Dekutoski, MD About

    Associate Professor, Dept. of Orthopaedics

    Mayo Clinic
    Rochester, MN

    Mark Dekutoski is Associate Professor of Orthopaedics at the Mayo Clinic, Rochester, MN. Dr. Dekutoski completed medical school and his residency training in general surgery and orthopaedic surgery at Wayne State University, Detroit, MI. He completed his fellowship at the Twin Cities Scoliosis Spine Center, University of Minnesota, Minneapolis, MN. Dr. Dekutoski is Board Certified. Today his practice is focused on adult and pediatric spinal deformity, spinal tumors, and degenerative disc disease.  Read More

  • Reginald Q. Knight, MD About

    Director

    Bassett Center for Spine Care
    Cooperstown, NY USA
     

    Dr. Reginald Knight is a Fellowship trained Board Certified Orthopedic Surgeon. Dr. Knight completed his Doctorate of Medicine at SUNY, NY and then completed a general surgery internship and orthopedic surgical residency at the New York Medical College. Dr. Knight completed his Fellowship in spinal surgery at the University of Rochester School of Medicine at Strong Memorial Hospital in Rochester, NY. Today, Dr. Knight is Director of the Bassett Healthcare Center for Spine Care.  His practice treats a broad spectrum of spinal disorders.   Read More

  • Daniel K. Resnick, MD About

    Associate Professor of Neurological Surgery

    University of Wisconsin School of Medicine
    Madison, WI

    Dr. Resnick completed medical school at the University of Pennsylvania, and then completed his residency training at the University of Pittsburgh. Currently, Dr. Resnick is Associate Professor of Neurological Surgery at the University of Wisconsin, Madison, WI, where he specializes in disorders of the spine. Dr. Resnick has particular expertise in minimally-invasive spine surgery, and the surgical management of spinal tumors and degenerative disorders of the spine.   Read More

Target Audience

This online continuing educational program has been designed to meet the educational needs of orthopaedic and neurological surgeons, interventional radiologists, primary care providers, and their fellows and residents, and other specialties involved in the care of patients with spinal disorders.

Educational Objectives

At the conclusion of the program, participants will be able to:

  • Describe prevalence and incidence data regarding vertebral compression fractures, and the related social impact and quality of life issues.
  • Discuss the treatment options for vertebral compression fractures.
  • Describe indications and patient selection considerations for treatment of vertebral compression fractures.

Statement of Educational Needs

While the medical literature regarding kyphoplasty and vertebroplasty procedures is extensive, a recent study of vertebroplasty in the New England Journal of Medicine1 called into question the efficacy of these treatments. The purpose of this program is to provide a scientifically rigorous and balanced review of the kyphoplasty and vertebroplasty techniques, indications, patient selection factors, and outcomes.

1. A Randomized Trial of Vertebroplasty for Osteoporotic Spinal Fractures, Kallmes et al, NEJM, Vol. 361:569-579.

Course Completion Time

Based upon trials, the estimated time to complete this program is 0.5 hour.

Sponsorship

This activity is jointly sponsored by Medical Education Resources, Inc., and BroadWater, LLC. MER Privacy Policy

Educational Grant

This activity is supported by educational grants from:

The Society for Minimally Invasive Spine Surgery (SMISS)
SMISS is a non-profit, charitable organization devoted to improving the health of patients with spinal disorders by advancing the highest quality minimally invasive spinal care for patients. (www.smiss.org)

Medtronic Spinal and Biologics Division
Medtronic Spinal and Biologics Division is a leader in the fields of spinal and musculoskeletal therapies. The company collaborates with world-renowned surgeons, researchers, and innovative partners to offer state-of-the-art therapies for spinal, neurological, orthopedic, and oral maxillofacial conditions.

Physician Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medical Education Resources, Inc. (MER) and BroadWater, LLC. Medical Education Resources is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Medical Education Resources designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Faculty Disclosure

In accordance with U.S. Food and Drug Administration (FDA) and ACCME guidelines, the financial and significant relationships to this program are listed below.

Mark B. Dekutoski, MD has indicated the following relevant financial relationships: Royalty (self): Mayo Clinic, Medtronic; Receipt of intellectual property rights/patent holder (self): Mayo Clinic, Medtronic, Perc. Trauma; Consultant fees (self): AO Foundation, Perc. Trauma, Vertical Health LLC

Reginald Q. Knight, MD has indicated the following relevant financial relationships: Research or institutional support has been received from Benvenue; Miscellaneous non-income support (eg, equipment or services), commercially-derived honoraria, or other non-research related funding (eg, paid travel) has been received from: Medtronic, Stryker; Royalties have been received from: Stryker; Consultant or employee: Medtronic, Stryker

Daniel K. Resnick, MD has indicated the following relevant financial relationships: Grant support: AHRQ, Multiple medical societies

Staff Disclosure

In accordance with U.S. Food and Drug Administration (FDA) and ACCME requirements, the relevant financial and significant relationships of staff/content advisors who have been involved with this program are disclosed below:

Jeremy Longhurst
No items to disclose.

Kamiah Walker
No items to disclose.

Method of Participation

There are no fees for participating in and receiving CME credit for this activity. During the period August 20, 2010 through August 19, 2011 participants must:

  1. read the learning objectives and faculty disclosures,
  2. study the educational activity,
  3. complete the posttest,
  4. complete the evaluation form, and
  5. submit the completed post test and evaluation form via www.SpineCME.org

Participants will be able to their statement of credit upon online submission of the completed posttest and evaluation with a score of 80% or better.

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of MER or BroadWater, LLC. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MER or BroadWater, LLC.

Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Purpose

This program is for educational and scientific purposes only. Any discussion of a product will be objective, balanced, and scientifically rigorous.

Off-Label/Investigational Use

It should be noted that specific medicines and medical devices discussed or referred to in this program may not yet be specifically cleared by the FDA for use in the United States. It is emphasized that package inserts must be referred to for labeling limitations for products used in the United States.

Software Requirements